胰十二指肠切除术后症状性边缘溃疡的长期并发症研究
停用质子泵抑制剂是独立危险因素,吸烟、饮酒及使用非甾体抗炎药亦增加风险,建议术后长期使用质子泵抑制剂。
要点
- 胰十二指肠切除术后边缘溃疡发生率为7.5%,中位诊断时间450天。
- 停用质子泵抑制剂是边缘溃疡的独立危险因素。
- 吸烟、饮酒、使用非甾体抗炎药增加边缘溃疡风险。
核心结论
- 边缘溃疡是胰十二指肠切除术后重要的长期并发症,停用质子泵抑制剂后更常见。
- 基于数据强烈建议术后永久使用质子泵抑制剂,尤其对吸烟、饮酒或使用非甾体抗炎药的患者。
研究设计与样本
- 回顾性分析前瞻性维护的胰十二指肠切除术患者数据库。
- 采用单因素和双变量竞争风险Cox回归分析识别边缘溃疡危险因素。
主要发现
- 19例(7.5%)诊断为边缘溃疡,中位诊断时间450天。
- 19例中13例表现为腹痛、黑便或贫血,均经质子泵抑制剂和内镜监测缓解。
- 6例表现为急腹症,因边缘溃疡穿孔和腹膜炎接受急诊剖腹探查。
- 无边缘溃疡相关死亡。
- 单因素和双变量竞争风险分析显示停用质子泵抑制剂、吸烟、饮酒和使用非甾体抗炎药增加边缘溃疡风险。
关键数值与推荐
- 停用质子泵抑制剂是边缘溃疡发生的独立危险因素。
- 推荐胰十二指肠切除术后永久使用质子泵抑制剂,尤其对吸烟、饮酒或使用非甾体抗炎药的患者。
临床怎么用
- 胰十二指肠切除术后应长期使用质子泵抑制剂,避免停药。
- 对吸烟、饮酒或使用非甾体抗炎药的患者,更应坚持质子泵抑制剂预防。
- 出现腹痛、黑便或贫血时需警惕边缘溃疡,及时内镜评估。
- 边缘溃疡穿孔可表现为急腹症,需急诊手术。
局限性
- 回顾性研究设计。
- 单中心数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Marginal ulcer is a well-known complication after pancreatoduodenectomy. In light of increasing long-term survival after pancreatoduodenectomy, the identification of risk factors and preventive strategies are of utmost importance. We assessed the incidence, clinical impact, and potential risk factors of marginal ulcer after pancreatoduodenectomy. METHODS: A prospectively maintained database of patients undergoing pancreatoduodenectomy was analyzed retrospectively. Univariate and bivariate competing-risk Cox regression analyses were performed to identify risk factors for marginal ulcer. RESULTS: Two hundred and fifty-five consecutive patients underwent pancreatoduodenectomy. The median follow-up was 35.7 months. Marginal ulcer was diagnosed in 19 patients (7.5%), and the median time from pancreatoduodenectomy to marginal ulcer diagnosis was 450 days. Thirteen of these 19 patients presented with abdominal pain, melena, or anemia. In all these 13 patients, marginal ulcer resolved with proton pump inhibitor therapy and endoscopic surveillance. Six patients with marginal ulcer presented with an acute abdomen and underwent emergency laparotomy for marginal ulcer perforation and peritonitis. There was no marginal ulcer-related mortality. Univariate and bivariate competing-risk analyses showed an increased risk for marginal ulcer with discontinuation of proton pump inhibitor therapy, smoking, alcohol intake, and the use of non-steroidal anti-inflammatory drugs. Discontinuation of proton pump inhibitor therapy was an independent risk factor for marginal ulcer development. CONCLUSION: Marginal ulcer is a relevant long-term complication after pancreatoduodenectomy that occurs more frequently after proton pump inhibitor therapy is discontinued. Based on our data, permanent use of proton pump inhibitor after pancreatoduodenectomy is strongly recommended especially for those patients who smoke, consume alcohol, or use non-steroidal anti-inflammatory drugs.
引用
- Sulieman I, Strobel O, Scharenberg C, et al. Symptomatic marginal ulcer after pancreatoduodenectomy. Surgery. 2020. PMID: 32276736. doi:10.1016/j.surg.2020.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。